SAN DIEGO, April 14, 2011 /PRNewswire/ -- Novo Nordisk presented data today that showed regardless of baseline A1C, once-daily Victoza® (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than some other commonly used type 2 diabetes therapies.

SAN FRANCISCO, Aug. 17 /PRNewswire/ -- The Juvenile Diabetes Research Foundation wants every Bay Area parent to be "T1D Aware" and recognize the telltale signs of type 1 diabetes in order to prevent a potentially deadly complication that often occurs as a result of a delayed diagnosis.

DENVER, Aug. 17 /PRNewswire/ -- The Juvenile Diabetes Research Foundation wants every Denver parent to be "T1D Aware" and recognize the telltale signs of type 1 diabetes in order to prevent a potentially deadly complication that often occurs as a result of a delayed diagnosis.

HOUSTON, Aug. 17 /PRNewswire/ -- The Juvenile Diabetes Research Foundation wants every Houston parent to be "T1D Aware" and recognize the telltale signs of type 1 diabetes in order to prevent a potentially deadly complication that often occurs as a result of a delayed diagnosis.

Scientists are reporting development and successful testing of a sensor that can instantly tell whether someone has Type I diabetes.